Clinical trial · Observational
Diet, Genetic Variation and Prostate Cancer Among African Americans
NCT00584792CI-TRIAL-00001080completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a single center pilot study to asses the feasibility of conducting a larger population-based study. It is an investigator-initiated study funded yb the UC Davis Cancer Center's Development Award Program. The hypothesis is that the percent african ancestry in an individual may determine their prognosis if diagnosed with prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- Controls (No prostate cancer)
- label
- 2
- description
- Cases (Prostate Cancer Diagnosed)
Primary outcomes (1)
- measure
- Is there a difference in ancestry percentage between the controls (no cancer) and the cases (prostate cancer)
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 35 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: Self-identification as a male with African ancestry Between ages of 35-75 Exclusion Criteria: No African ancestry Not between ages of 35-75 \-
References
Publications (0)
Data not yet available
No reference posted for this study.